My da|ra Login

Detailed view

metadata language: German English

Epidemiological Survey on Substance Abuse in Germany 2012 (ESA)

Version
1.0.0
Resource Type
Dataset
Creator
  • Institut für Therapieforschung (IFT), München
  • Institut für Klinische Psychologie und Psychotherapie der Technischen Universität Dresden
  • Bundesministerium für Gesundheit und soziale Sicherung, Berlin
Publication Date
2014-09-09
Contributor
  • infas, Bonn (Data Collector)
Language
German
Classification
  • ZA:
    • Society, Culture
    • Medicine
Description
  • Abstract

    Questions about health. Questions about medications, smoking, alcohol and drug consumption. Topics: 1. Questions on health: Self-assessment of the state of health and psychological well-being; frequency of nervousness, hopelessness, restlessness, feeling of despondence, overexertion and worthlessness in the last month; detailed indication of chronic diseases. 2. Use of medications: type of medication (painkillers, sleeping pills, sedatives, stimulants, appetite suppressants, antidepressants, neuroleptics and anabolic steroids (anabolic steroids) in the last 12 months; frequency of use of painkillers, sleeping pills, sedatives, stimulants, appetite suppressants, antidepressants and neuroleptics in the last 30 days and respective prescription by a physician; frequency of taking anabolic steroids to support sporting activities in the last month; taking painkillers, sleeping pills or tranquilizers in the last year; addiction tendencies: in relation to the last 12 months for painkillers, sleeping pills and sedatives: considerable problems in connection with taking the medication (e.g. neglect of household and children, poor performance), injury-endangering situations under the influence of medication, accidental injuries such as accident or fall, legal problems, accusations from family or friends, broken relationships, financial difficulties, physically assaulting someone, or injured, taken in larger quantities, or for longer periods of time than prescribed by a doctor or intended to cause discomfort when discontinuing the treatment. and subsequent further use to avoid the risk of discomfort, higher doses required for desired effect or weakened effect, unsuccessful attempts to reduce the consumption of medication, and reduce or adjust, high expenditure of time for the procurement of medication or recovery from the effects, restriction of activities, taking medication despite knowledge about harmful effect, craving for medication so strong that resistances or other thoughts were not possible; perceived harmful effect of medicine use on one´s own health or one´s own life; offers of assistance taken advantage of on the basis of medicine use (family doctor, psychotherapy, outpatient addiction counselling, inpatient detoxification or rehabilitation, self-help group, support from friends, partner or family). 3. Smoking: smokerr status; smoking behaviour: more than 100 tobaccos in total (cigarettes, cigars, etc.) smoked during the course of life; types of tobaccos (cigarettes, cigars, cigarillos, pipes, shisha, etc.) shisha smoked in the last 12 months; age at the beginning of tobacco consumption and at the beginning of daily life smoking; years of smoking; time of last tobacco consumption; specific number of days in the last month on which cigarettes (or cigars, cigarillos or pipes) were smoked and average smoked number per day; average daily consumption of more than 20 cigarettes or 10 cigarillos (7 pipes, 5 cigars) in the last 12 months; addiction tendencies (increase in consumption, decreasing effect, smoked more than intended, unsuccessful attempts to quit smoking; years of smoking; time of last tobacco consumption; specific number of days in the last month on which cigarettes (or cigars, cigarillos or pipes) were smoked and average smoked number per day; average daily consumption of more than 20 cigarettes or 10 cigarillos (7 pipes, 5 cigars) in the last 12 months; addiction tendencies (increase in consumption, decreasing effect, smoked more than intended, unsuccessful attempts with the quitting smoking, chain smoking, interruption of important activities because of smoking, smoking despite serious illness, impairment at work, at school or in the household by smoking, smoking in bed or when dealing with flammable substances, continue to smoke even though family or friends were annoyed or unhappy); desire for tobacco so strong that resistances or other thoughts were not possible; continue smoking in spite of physical or psychological complaints; complaints during the attempt to give up smoking (depression, insomnia, irritability, anxiety, restlessness, lack of concentration, slow heartbeat and weight gain); resuming smoking to reduce or avoid such complaints; timing and success of the last serious weaning attempt; aids used during the last weaning attempt. 4. Alcohol consumption: age at first glass of alcohol; alcohol consumption at least once a month; starting age at regular intervals of alcohol consumption; alcoholic excesses (intoxication) in the past and frequency of alcohol excesses in the last 12 months; age at which first alcoholic process; time of the last alcohol consumption; total number of days of alcohol consumption in the last four weeks, or in the last 12 months; concrete indication of the average number of days of alcohol consumption in the last four weeks or consumed quantities of beer, wine, sparkling wine, spirits and alcoholic mixed drinks (e.g. alcopops) in the last four weeks or in the last 12 months; number of days with consumption of at least five glasses of alcohol in the last 30 days or 12 months; alcohol consumption in the last 12 months: considerable difficulties at work, at school or at home due to alcohol; situations that can lead to injury under the influence of alcohol; anger with the Police (e.g. for drink driving or rioting); accusations from family or friends because of alcohol; failed relationships because of alcohol consumption; financial difficulties because of alcohol consumption; physical attacks or injuries to third parties under the influence of alcohol; addiction tendencies in the last 12 months: more alcohol consumed than before to achieve the same effect; the same amount of alcohol had less effect than before; more, more frequently or over a longer period of time than intended drunk; difficulty to stop drinking before intoxication; unsuccessful attempts to reduce alcohol consumption or stop drinking altogether; prolonged consumption of alcohol over several days with drunkenness or hangover; restriction or abandonment of important activities because of alcohol consumption; craving for alcohol so strong, that resistances or other thoughts were not possible; physical complaints (withdrawal symptoms) with restricted alcohol consumption or abstinence (trembling, insomnia, anxiety, sweating, hallucinations, seizures, nausea, vomiting, urge to move, tachycardia); alcohol consumption to reduce or avoid these physical discomfort; physical diseases or mental illness problems caused by alcohol consumption; continued alcohol consumption despite knowledge about this problem; perceived harmful effect on health through the consumption of alcohol; used help offers due to alcohol consumption (family doctor, psychotherapy, outpatient addiction counselling, inpatient detoxification or rehabilitation, self-help group, support from friends, partners or family); concern about the alcohol consumption of another person (family or marital problems, in the car of an alcoholic, involvement in a car accident caused by an alcoholic person, financial problems, physical injury or destroyed clothes by a drunken person, invectiveness or defamation, being kept awake at night, harassment or disturbance on the premises on the street or in public places as well as in a private setting, e.g. at a party, frightened by drunken people on the street). 5. Drug use: access to illegal drugs; drug experience with Cannabis (hashish, marijuana), stimulants, amphetamines, Ecstasy, LSD, heroin, other opiates such as methadone, cocaine, crack cocaine, Spice, Smoke, Space, Bath salts, Cathinone, Sniffers(adhesives, solvents, propellants) and mushrooms (toadstools, Magic Mushrooms (Psilocybin)); generally tried drugs; starting age at selected drugs, sniffing substances and mushrooms; concrete specification of the frequency of consumption of illicit drugs, sniffing substances and mushrooms in total and in the last 12 months; date of the last drug use (in the last four weeks, in the last 12 months or before); the concrete number of days on which selected illegal drugs, sniffing substances, mushrooms etc. were consumed (in terms of the last 30 days); problems related to the use of cannabis or cocaine or amphetamines in the last 12 months: substantial problems at work, neglect of household and children,(poor performance), situations that could lead to injury under drug influence, own accident after drug use, legal problems e.g. because of drug possession, accusations from family or friends because of drugs, failed relationships due to drug use, financial difficulties, physical assaults or injuries to third parties under drug influence, more drugs consumed than before to achieve the same effector the same amount of drugs had a lesser effect than earlier; complaints (withdrawal symptoms) with restricted drug consumption or drug abstinence (tremors, insomnia, anxiety, sweating, tachycardia, irritability, depression); drug use to reduce or prevent these symptoms; to be taken in larger quantities of drugs or for longer periods than intended; desire to reduce drug use or unsuccessful attempts; time spent on drug procurement, drug use, or the recovery phase; restriction or abandonment of important activities because of drug use; health problems related to the use of drugs (e.g. persistent cough, circulatory problems),hoarseness, nausea, dryness of the eyes and mouth); continued drug use in spite of health problems; emotional or psychological problems caused by drug use (disinterestedness, dejectedness, suspicion, feeling persecuted. ideas); continued drug use despite these mental problems; desire for drugs so strong that other thoughts are not possible; the perceived harmful effect on health due to the consumption of illegal drugs; assistance used on the basis of the consumption of illegal drugs (family doctor, psychotherapy, outpatient addiction counselling, inpatient detoxification or rehabilitation, self-help group, support from friends, partners or family). Demography: sex; age (year of birth); country of birth; duration of residence in Germany; German or other citizenship; country of birth, German or other citizenship of the parents as well as duration of residence of the parents in Germany (migration background); body size in centimeters; body weight in kilograms; marital status; living together with a partner; number of children; number of children in the household; household size; number of persons in the household under 14 years of age; highest school-leaving certificate; desired school-leaving certificate; highest professional graduation; current employment or previous employment; occupational status of current or former employment; respondent is the main wage earner in the household; occupational status of main wage earner; net household income; questionnaire filled out alone. Additionally coded was: sex, year of birth, nationality and age group according to residents´ registration office; sample identification; federal state; city size (political and BIK community size class); administrative district; West East identifier; type of interview; weighting factors.
Temporal Coverage
  • 2012-04 / 2012-08
Geographic Coverage
  • Germany (DE)
Sampled Universe
All persons living in private households who were born between 1948 and 1994, i.e. persons aged between 18 and 64. For the increase for the federal state of Berlin, the birth cohorts 1995 to 1997 were complemented, i.e. persons aged 15 to 17.
Sampling
Sample from the residents´ registration office Additional samples for the federal states of Berlin and Thuringia
Collection Mode
  • The study was conducted using a mixed mode design: Self-administered questionnaire: Paper (in the data set named as PAPI) Telephone interview: CATI (Computer Assisted Telephone Interview) Self-administered questionnaire: CAWI (Computer Assisted Web Interview)
Data and File Information
  • Number of Variables: 553
Availability
Delivery
C - Data and documents are only released for academic research and teaching after the data depositor’s written authorization. For this purpose the Data Archive obtains a written permission with specification of the user and the analysis intention.
Rights
All metadata from GESIS DBK are available free of restriction under the Creative Commons CC0 1.0 Universal Public Domain Dedication. However, GESIS requests that you actively acknowledge and give attribution to all metadata sources, such as the data providers and any data aggregators, including GESIS. For further information see https://dbk.gesis.org/dbksearch/guidelines.asp
Alternative Identifiers
  • ZA5787 (Type: ZA-No.)
Publications
  • Steinwede, Angelika; Kleudgen, Martin; Bech, Katalin: Bericht: Epidemiologischer Suchtsurvey 2012. Bonn: infas 2012
  • Kraus, Ludwig; Piontek, Daniela; Pabst, Alexander: Studiendesign und Methodik des Epidemiologischen Suchtsurveys 2012. In: Sucht Jg. 59, 2013, Nr. 6, S. 309-320

Update Metadata: 2019-02-11 | Issue Number: 9 | Registration Date: 2014-09-09

Institut für Therapieforschung (IFT), München; Institut für Klinische Psychologie und Psychotherapie der Technischen Universität Dresden; Bundesministerium für Gesundheit und soziale Sicherung, Berlin (2014): Repräsentativerhebung zum Gebrauch und Missbrauch psychoaktiver Substanzen bei Erwachsenen in Deutschland (Epidemiologischer Suchtsurvey 2012). Version: 1.0.0. GESIS Datenarchiv. Dataset. https://doi.org/10.4232/1.12042